Feng Hao, Pyykkö Ilmari, Zou Jing
Hearing and Balance Research Unit, Field of Oto-laryngology, School of Medicine, University of Tampere, Medisiinarinkatu 3, 33520, Tampere, Finland.
Department of Otolaryngology-Head and Neck Surgery, Center for Otolaryngology-Head and Neck Surgery of Chinese PLA, Changhai Hospital, Second Military Medical University, Shanghai, China.
Nanoscale Res Lett. 2016 Dec;11(1):240. doi: 10.1186/s11671-016-1430-9. Epub 2016 May 4.
Silver nanoparticles (AgNPs) were shown to temporarily impair the biological barriers in the skin of the external ear canal, mucosa of the middle ear, and inner ear, causing partially reversible hearing loss after delivery into the middle ear. The current study aimed to elucidate the molecular mechanism, emphasizing the TLR signaling pathways in association with the potential recruitment of macrophages in the cochlea and the modulation of inflammation by ubiquitin-editing protein A20. Molecules potentially involved in these signaling pathways were thoroughly analysed using immunohistochemistry in the rat cochlea exposed to AgNPs at various concentrations through intratympanic injection. The results showed that 0.4 % AgNPs but not 0.02 % AgNPs upregulated the expressions of CD68, TLR4, MCP1, A20, and RNF11 in the strial basal cells, spiral ligament fibrocytes, and non-sensory supporting cells of Corti's organ. 0.4 % AgNPs had no effect on CD44, TLR2, MCP2, Rac1, myosin light chain, VCAM1, Erk1/2, JNK, p38, IL-1β, TNF-α, TNFR1, TNFR2, IL-10, or TGF-β. This study suggested that AgNPs might confer macrophage-like functions on the strial basal cells and spiral ligament fibrocytes and enhance the immune activities of non-sensory supporting cells of Corti's organ through the upregulation of CD68, which might be involved in TLR4 activation. A20 and RNF11 played roles in maintaining cochlear homeostasis via negative regulation of the expressions of inflammatory cytokines.
银纳米颗粒(AgNPs)被证明会暂时损害外耳道皮肤、中耳黏膜和内耳的生物屏障,在注入中耳后会导致部分可逆性听力损失。当前研究旨在阐明分子机制,重点关注与耳蜗中巨噬细胞潜在募集以及泛素编辑蛋白A20对炎症调节相关的Toll样受体(TLR)信号通路。通过鼓膜内注射,使用免疫组织化学方法对暴露于不同浓度AgNPs的大鼠耳蜗中可能参与这些信号通路的分子进行了全面分析。结果显示,0.4%的AgNPs而非0.02%的AgNPs上调了血管纹基底细胞、螺旋韧带纤维细胞以及柯蒂氏器非感觉支持细胞中CD68、TLR4、单核细胞趋化蛋白1(MCP1)、A20和环指蛋白11(RNF11)的表达。0.4%的AgNPs对CD44、TLR2、单核细胞趋化蛋白2(MCP2)、Rac1、肌球蛋白轻链、血管细胞黏附分子1(VCAM1)、细胞外信号调节激酶1/2(Erk1/2)、应激活化蛋白激酶(JNK)、p38、白细胞介素-1β(IL-1β)、肿瘤坏死因子-α(TNF-α)、肿瘤坏死因子受体1(TNFR1)、肿瘤坏死因子受体2(TNFR2)、白细胞介素-10(IL-10)或转化生长因子-β(TGF-β)没有影响。本研究表明,AgNPs可能赋予血管纹基底细胞和螺旋韧带纤维细胞类似巨噬细胞的功能,并通过上调可能参与TLR4激活的CD68来增强柯蒂氏器非感觉支持细胞的免疫活性。A20和RNF11通过对炎性细胞因子表达的负调节在维持耳蜗内环境稳定中发挥作用。